TW200706173A - Oral composition comprising carbamylating agent - Google Patents
Oral composition comprising carbamylating agentInfo
- Publication number
- TW200706173A TW200706173A TW094126807A TW94126807A TW200706173A TW 200706173 A TW200706173 A TW 200706173A TW 094126807 A TW094126807 A TW 094126807A TW 94126807 A TW94126807 A TW 94126807A TW 200706173 A TW200706173 A TW 200706173A
- Authority
- TW
- Taiwan
- Prior art keywords
- oral composition
- carbamylating agent
- agent
- carbamylating
- diluent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- VNYBTNPBYXSMOO-UHFFFAOYSA-M Pyridostigmine bromide Chemical compound [Br-].CN(C)C(=O)OC1=CC=C[N+](C)=C1 VNYBTNPBYXSMOO-UHFFFAOYSA-M 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229960002151 pyridostigmine bromide Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58434904P | 2004-06-30 | 2004-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200706173A true TW200706173A (en) | 2007-02-16 |
Family
ID=35783388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094126807A TW200706173A (en) | 2004-06-30 | 2005-08-08 | Oral composition comprising carbamylating agent |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW200706173A (zh) |
| WO (1) | WO2006005017A2 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2356984A1 (en) * | 2010-02-04 | 2011-08-17 | Nycomed Austria GmbH | Improved distigmine bromide formulation |
| EP3589369A4 (en) | 2017-01-09 | 2020-03-18 | DAS-MG, Inc. | USE AND COMPOSITION FOR TREATING SEVERE MYASTHENIA AND OTHER MYASTHENIC SYNDROMES |
| WO2019023318A1 (en) | 2017-07-25 | 2019-01-31 | Gt Biopharma, Inc. | PHARMACEUTICAL COMPOSITIONS AND METHODS USING PYRIDOSTIGMINE AND AN ANTAGONIST OF NK-1 FOR TREATING SEVERE MYASTHENIA |
| WO2019023175A1 (en) * | 2017-07-25 | 2019-01-31 | Gt Biopharma, Inc. | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AND NEOSTIGMINE AND AN ANTAGONIST NK-1 FOR THE TREATMENT OF SEVERE MYASTHENIA |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
-
2005
- 2005-06-30 WO PCT/US2005/023624 patent/WO2006005017A2/en not_active Ceased
- 2005-08-08 TW TW094126807A patent/TW200706173A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006005017A3 (en) | 2006-04-20 |
| WO2006005017A2 (en) | 2006-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07235A1 (en) | Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride | |
| MX2009005462A (es) | Analogos de 7,8-saturados-4,5-epoxi-morfinano. | |
| UA94417C2 (ru) | Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение | |
| TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
| MX2009005461A (es) | N-oxidos de analogos de 4,5-epoxi-morfinano. | |
| MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
| MX2007003078A (es) | Compuestos de imidazoquinolina. | |
| TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
| SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
| MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
| AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
| MX2007001035A (es) | Metodo para producir una composicion, la composicion y su uso. | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| TNSN06222A1 (en) | Pharmaceutical formulations comprising metformin and a fibrate, and processes for obtaining them | |
| TW200745122A (en) | New compounds I | |
| TW200738649A (en) | Calcilytic compounds | |
| TW200833371A (en) | Process for solid formulations | |
| TW200640857A (en) | Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof | |
| WO2006056696A3 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation | |
| TW200700071A (en) | Novel use | |
| WO2010023473A3 (en) | Crystalline form of sunitinib and processes for its preparation | |
| MX2007006042A (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion. | |
| TNSN07241A1 (en) | Substituted pyrroles, compositions containing same, method for making same and use thereof | |
| MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| MXPA03008801A (es) | Aril oxima-piperazinas utiles como antagonistas de ccr5. |